InvestorsHub Logo
Followers 88
Posts 5985
Boards Moderated 0
Alias Born 03/19/2007

Re: Alydyr post# 18119

Friday, 11/21/2014 12:57:19 AM

Friday, November 21, 2014 12:57:19 AM

Post# of 97081
All this Information could have taken from various press-Releases and even from other boards in Europe.

When Reuters released the talk between J&J and the Carlyle Group in January 2014 this was not even new, as those discussions even went back to early 2013.

Then on 2013 there were already hints the Life-Scan is searching as well directly for a buyer.

Originally Posted by Anonymous View Post

Had to dig to find this.

http://www.investor.jnj.com/released...


« Previous Release | Next Release »


October 15, 2013

LifeScan Announces Definitive Agreement To Divest SMBG Business

Milpitas, CA, October 15, 2013 - LifeScan today announced a definitive agreement to divest the assets of its OneTouch line of blood glucose monitoring business unit to subsidiaries of Roche Pharmaceuticals International, Inc. for approximately $2.6 billion in cash. The divestiture of LifeScan NA assets includes brands (ONETOUCH®, VERIO IQ® and DELICA®) sold in the U.S. LifeScan NA will continue to promote the Animas line of insulin pump therapy products in both the US and Canadian markets.

The transaction is expected to close by year-end, subject to customary closing conditions.

# # #

LifeScan, Inc. is a leading maker of blood glucose monitoring systems for people with diabetes. For information about diabetes care and LifeScan products and services, visit http://www.onetouch.com.

# # #

Close window | Back to top
delicious Digg Facebook LinkedIn Mixx Twitter Yahoo! Buzz

All we know today, the deal never went trough. So it is back to J&J to get rid of Lifescan.